Spectrum Pharmaceuticals Inc (SPPI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SPPI Annual Balance Sheets →
Looking at balance sheet data from Spectrum Pharmaceuticals Inc through Mar 31 2022 provides insight into Mar 31 2023's solvency and capital structure over time.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2023)
(Dec 31 2022) (Sep 30 2022) (Jun 30 2022) (Mar 31 2022)
Assets
Cash & cash equivalent52.37
Short-term Investments, Total3.76
Cash & Short-term Investments55.00
Accounts receivable32.76
Nontrade Receivables0.88
Inventories12.86
Prepaid Expense And Other Assets Current2.74
Total Current Assets105.38
Equipment/Property/Plant Net0.53
Other Assets, Noncurrent1.00
Operating Lease Right Of Use Asset1.52
Total Assets107.68
Liabilities
Accounts Payable and Other Accrued Liabilities, Current35.38
Accrued Employee Benefits, Current3.50
Other Liabilities, Current0.00
Total Current Liabilities38.88
Long-term debt28.84
Total Long-term Debt28.84
Other liabilities, Noncurrent13.15
Total Liabilities80.87
Stockholders' Equity
Common Stock Value0.21
Additional Paid In Capital Common Stock1,153.82
Retained Earnings / Accumulated Deficit-1,124.33
Other Equity-2.89
Common Stockholder's Equity26.81
Total Stockholder's Equity26.81
Liabilities & Stockholder's Equity107.68
4 historic quarters locked

Sign in to unlock the full Spectrum Pharmaceuticals Inc balance sheet history.

About Spectrum Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000831547-23-000012

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.